Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography

British Journal of Cancer

Volumn 73, Issue 2, 1996, Pages 162-168

  Graham, S J ^a   Bronskill, M J ^a   Byng, J W ^a   Yaffe, M J ^a   Boyd, N F ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Breast cancer; Magnetic resonance; Relaxation time; Risk assessment; Water content; X ray mammography

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; BREAST; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; DEMOGRAPHY; DENSITY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MAMMOGRAPHY; MONITOR; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; RISK ASSESSMENT; WATER CONTENT;

EID: 0030053572     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.30     Document Type: Article

References (39)

1. BOTTOMLEY PA, FOSTER TH, ARGERSINGER RE AND PFEIFER LM. (1984). A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1 - 100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med. Phys., 11, 425-447.
2. BOYD NF, COUSINS M, LOCKWOOD G AND TRITCHLER D. (1990). The feasibility of testing experimentally the dietary fat breast cancer hypothesis. Br. J. Cancer, 62, 878-881.
3. BOYD NF, JENSEN HM, COOKE G AND LEE HAN H. (1992). Relationship between mammographic and histological risk factors for breast cancer. J. Natl Cancer Inst., 84, 1170-1179.
4. BOYD NF, BYNG JW, JONG RA, FISHELL EK, LITTLE LE, MILLER AB, LOCKWOOD GA, TRITCHLER DL AND YAFFE MJ. (1995). Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J. Natl Cancer Inst., 87, 670-675.
5. BRISSON JB, MERLETTI F, SADOWSKI NL, TWADDLE JA, MORRISON AS AND COLE P. (1982). Mammographic features of the breast and breast cancer risk. Am. J. Epidemiol., 115, 428-437.
6. BYNG JW, BOYD NF, FISHELL E, JONG RA AND YAFFE MJ. (1994). The quantitative analysis of mammographic densities. Phys. Med. Biol., 39, 1629-1638.
7. BYNG JW, BOYD NF, LITTLE L, LOCKWOOD G, FISHELL E, JONG RA AND YAFFE MJ. (1995). Symmetry of projection in the quantitative analysis of mammographic images. Eur. J. Cancer Prev., (submitted).
8. CARR HY AND PURCELL EM. (1954). Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys. Rev., 94, 630-638.
9. DIXON WT. (1984). Simple proton spectroscopic imaging. Radiology, 153, 189-194.
10. GOODWIN PJ AND BOYD NF. (1988). Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am. J. Epidemiol., 127, 1097-1108.
11. GRAHAM SJ AND BRONSKILL MJ. (1995). MR measurement of relative water content and multicomponent T2 relaxation times applied to human breast. Magn. Reson. Med., (in press).
12. GRAHAM SJ, STANCHEV PL, LLOYD-SMITH JOA AND BRONSKILL MJ. (1995a). Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by magnetic resonance imaging at 1.5 T. J. Magn. Reson. Imaging, 5, 695-701.
13. GRAHAM SJ, STANCHEV PL AND BRONSKILL MJ. (1995b). Multicomponent T2 Relaxation analysis of data measured on clinical MR scanners. Magn. Reson. Med., (in press).
14. HAYS WL AND WINKLER RL. (1971). Statistics: Probability, Inference, and Decision. Holt, Rinehart & Winston: New York.
15. HORE PJ. (1983). Solvent suppression in Fourier transform nuclear magnetic resonance. J. Magn. Reson., 55, 283-300.
16. HUNTER DJ AND WILLETT WC. (1993). Diet, body size and breast cancer. Epidemiol. Rev., 15, 110-132.
17. KAIZER L, FISHELL EK, HUNT JW, FOSTER FS AND BOYD NF. (1988). Ultrasonographically defined parenchymal patterns of the breast: relationship to mammographic patterns and other risk factors for breast cancer. Br. J. Radiol., 61, 118-124.
18. KELSEY JL, HILDRETH NG AND THOMPSON WD. (1983). Epidemiologic aspects of breast cancer. Radiol. Clin. North Am., 21, 3-12.
19. MACKAY AL, WHITTALL KP, ADLER J, LI D, PATY DW AND GRAEB D. (1994). In vivo visualization of myelin water in brain by magnetic resonance. Magn. Reson. Med., 31, 673-677.
20. MCSWEENEY MB, SMALL WC, CERNY V, SEWELL W, POWELL RW AND GOLDSTEIN JH. (1984). Magnetic resonance imaging in the diagnosis of breast disease: use of transverse relaxation times. Radiology, 153, 741-744.
21. MEIBOOM S AND GILL D. (1958). Modified spin-echo method for measuring nuclear relaxation times. Rev. Sci. Instr., 29, 688-691.
22. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNETT LM, DING W, BELL R, ROSENTHAL J, HUSSEY C, TRAN T, MCCLURE M, FRYE C, HATTIER T, PHELPS R, HAUGEN-STRANO A, KATCHER H, YAKUMO K, GHOLAMI Z, SHAFFER D, STONE S, BAYER S, WRAY C, BOGDEN R, DAYANANTH P, WARD J, TONIN P, NAROD S, BRISTOW PK, NORRIS FH, HELVERING L, MORRISON P, ROSTECK P, LAI M, BARRETT JC, LEWIS C, NEUHAUSEN S, CANNON-ALBRIGHT L, GOLDGAR D, WISEMAN R, KAMB A AND SKOLNICK MH. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
23. MILLER AB, BAINES CJ, TO T AND WALL C. (1992a). Canadian National Breast Screening Study.2. breast cancer detection and death rates among women aged 50 to 59 years. Can. Med. Assoc. J., 147, 1477-1488.
24. MILLER AB, BAINES CJ, TO T AND WALL C. (1992b). Canadian National Breast Screening Study.1. breast cancer detection and death rates among women aged 40 to 49 years. Can. Med. Assoc. J., 147, 1459-1476.
25. NAYFIELD SG, KARP JE, FORD LG, DORR FA AND KRAMER BS, (1991). Potential role of tamoxifen in prevention of breast cancer. J. Natl Cancer Inst., 83, 1450-1459.
26. POON CS, SZUMOWSKI J, PLEWES DB, ASHBY P AND HENKELMAN RM. (1989). Fat/water quantitation and differential relaxation time measurement using chemical shift imaging technique. Magn. Reson. Imaging, 7, 369-382.
27. POON CS, BRONSKILL MJ, HENKELMAN RM AND BOYD NF. (1992). Quantitative magnetic resonance parameters and their relationship to mammographic pattern. J. Natl Cancer Inst., 84, 777-781.
28. SAFTLAS AF AND SZKLO M. (1987). Mammographic parenchymal patterns and breast cancer risk. Epidemiol. Rev., 9, 146-174.
29. SCHECHTER MT, MILLER AB AND HOWE GR. (1985). Cigarette smoking and breast cancer: a case - control study of screening program participants. Am. J. Epidemiol., 121, 479-487.
30. SEIDMAN H, STELLMAN S AND MUSHINKI MH. (1982). A different perspective on breast cancer risk factors: some implications of the nonattributable risk. CA, 32, 301-313.
31. SMALL WC, MCSWEENEY MB, GOLDSTEIN JH, SEWELL W AND POWELL RW. (1983). Handling of in vitro human breast tissue samples: protocol requirements for accurate NMR relaxation measurements. Biochem. Biophys. Res. Commun., 112, 991-999.
32. SPICER DV, URSIN G, PARISKY YR, PEARCE JG, SHOUPE D, PIKE A AND PIKE MC. (1994). Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J. Natl Cancer Inst., 86, 431-436.
33. TABAR L AND DEAN PB. (1982). Mammographic parenchymal patterns: risk indicator for breast cancer? JAMA, 247, 185-189.
34. WARNER E, LOCKWOOD G, TRITCHLER D AND BOYD NF. (1992). The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect. Prev., 16, 67-72.
35. WHITTALL KP AND MACKAY AL. (1989). Quantitative interpretation of NMR relaxation data. J. Magn. Reson., 84, 134-152.
36. WOLFE JN. (1976). Breast patterns as an index of risk of developing breast cancer. Am. J. Roentgenol., 126, 1130-1139.
37. WOODARD HQ AND WHITE DR. (1986). The composition of body tissues. Br. J. Radiol., 59, 1209-1219.
38. WOOSTER R, NEUHAUSEN SL, MANGION J, QUIRK Y, FORD D, COLLINS N, NGUYEN K, SEAL S, TRAN T, AVERILL D, FIELDS P, MARSHALL G, NAROD S, LENOIR GM, LYNCH H, FEUNTEUN J, DEVILEE P, CORNELISSE CJ, MENKO FH, DALY PA, ORMISTON W, MCMANUS R, PYE C, LEWIS CM, CANNON-ALBRIGHT LA, PETO J, PONDER BAJ, SKOLNICK MH, EASTON DF, GOLDGAR DE AND STRATTON MR. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265, 2088-2090.
39. YIN F-F, GIGER ML, DOI K, YOSHIMURA H, XU X-W AND NISHIKAWA RM. (1992). Evaluation of imaging properties of a laser film digitizer. Phys. Med. Biol., 37, 273-280.